API
< Back to all clusters
[HEALTH] · Canada, United States, Spain, France, Israel · 6 sources

started · updated

WHO reports global spread of COVID-19 variant PJ.2.1

The World Health Organization (WHO) has confirmed the global spread of the COVID-19 variant PJ.2.1. First identified in Ontario, Canada, on May 2, 2026, the variant has since been detected in several Canadian provinces, various U.S. states, Spain, France, Israel, Singapore, Australia, and New Zealand.

Symptoms of PJ.2.1 closely resemble those of the common cold and seasonal influenza, including fever, cough, sore throat, runny or blocked nose, headache, muscle aches, and fatigue. Due to this overlap, health officials emphasize that diagnostic testing is essential to distinguish the variant from other respiratory infections.

While the variant possesses mutations in its spike protein that may affect its interaction with human cells, current laboratory and clinical data show no evidence that PJ.2.1 causes more severe illness or higher hospitalization rates compared to previous variants. However, vulnerable populations, such as the elderly and those with chronic health conditions, may still face higher risks.

Entities

Canada · Elena Malenikova · Europe · North America · Ontario · SARS-CoV-2 · United States · World Health Organization

Claims

What the coverage asserts, and how many sources carry each claim.